Phase 1 Trials of Bayer’s Cell and Gene Therapies Enrolling Patients,

A first patient has been dosed in a still-recruiting Phase 1 clinical trial testing DA01, an investigational cell therapy for Parkinson’s disease. A separate …, A first patient has been dosed in a still-recruiting Phase 1 clinical trial testing DA01, an investigational cell therapy for Parkinson’s disease. A separate …, Read More

Scroll to Top